Fempharma
About Fempharma
Certifications
Categories
-
HU
-
2021On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Products from Fempharma (5)
-
Product TRIPHASIN - Special food supplement adjusted to the phases of the menstrual cycle
Triphasin is a unique dietary supplement adjusted to the phases of the menstrual cycle of women. The product is intended to support the wellbeing of women during the whole menstrual cycle, by satisfying the specific vitamin and mineral demands of the female body according to the relevant phases of the mens... -
Product JUVIAGEL – Vaginal moisturizing gel
Problem
Vaginal dryness (or atrophy) is a condition caused by a decreased level of the oestrogen hormone. It is characterized by a thinning, dehydrated and possibly inflamed vaginal wall. A dry vagina means uncomfortable or painful sex. In more severe cases it may cause a dry, itchy or even b... -
Product MOMAID – Postpartum Recovery Supplement
Problem Pregnancy and birth places increased stress on the pelvic floor leaving the muscles fatigued and weak. The risk of pelvic floor injury increases with each pregnancy, and it is also associated with age at first vaginal delivery. Regeneration of pelvic floor muscles is important to prevent pelvic flo... -
Product CORTEXIUM - food supplement for improving brain function and concentration
CORTEXIUM is designed to enhance brain function, improve concentration, and reduce fatigue by providing a blend of scientifically proven ingredients.
It fills this gap by offering a synergistic blend of ingredients such as GABA, essential vitamins, minerals, and PQQ to enhance brain ... -
Product INCOXIL - Stronger pelvic floor muscles and less urinary incontinence
Unmet need
25 to 57 % of all women in the U.S. experience urinary incontinence (UI). In the USA UI is a significant economic burden.
Solution
Pelvic floor muscle training (PFMT) is globally recommended as part of first-line treatment and is proven to work for ...
Fempharma Resources (2)
-
News Zinc containing vaginal gel shows promise as surprising emerging treatment for vaginal yeast infections.
Around three quarters of women develop vaginal yeast infections at least once in their lifetime, and approximately 140 million women globally suffer from recurrent infections. Recurrent yeast infections can have an enormous impact of quality of life. Existing anti-fungal treatments are not always effective and resistance against these treatments is developing. Vaginal yeast infection is caused by a yeast called Candida.
In a paper, published in Science Translational Medicine, we have shown that JUVIAGEL could be effective against recurrent yeast infections. -
Brochure Fempharma's portfolio
The document introduces our product portfolio.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance